International Markets and Developments for Medical Devices
摘要
The global medical device industry operates across continents, driven by complex regulations, trade, and diverse healthcare needs. Since 2000, the market has grown from about USD 140–160 billion to roughly USD 675 billion in 2024, with North America leading and Asia-Pacific rapidly expanding. Major product categories like in vitro diagnostics, cardiology, orthopedics, and imaging dominate revenues, with digital health showing the fastest growth. International trade has also surged, exceeding USD 680 billion in 2022, facilitated by key exporters and importers such as the USA, Europe, and China. Demand is fueled by demographic aging, rising incomes, chronic disease prevalence, technological innovation, and health system capacity. However, growth risks include supply chain complexity, regulatory, geopolitical tensions, reimbursement, economic instability, clinical adoption, and unequal healthcare infrastructure across regions. If the growth rates observed in recent years are assumed for the four submarkets, the global market for medical devices is expected to grow from USD 675 billion (2024) to approximately USD 870 billion (2030). North America will continue to dominate the market with a 50% share.